Definitive Contract 75F40123C00138
Award Date
9/5/23
Potential Completion Date
9/28/26
Potential Value
$1.2M
Federal Agency
Food and Drug Administration
Awardee
Duke University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
10
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) has awarded a $749,661.00 firm fixed-price definitive contract to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is not set-aside and was issued under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. The BAA solicits basic and applied research and development proposals to support the FDA's mission of protecting and promoting...
The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
The U.S. government awarded Duke University, a private non-profit educational institution, a $2,359,896.00 cost-no-fee definitive contract for biomedical (applied/exploratory) research and development services. This contract does not have a set-aside designation. Duke University's Office of Research Administration Division is serving as the prime contractor. The contract was awarded on September 17, 2003 with a completion date of April 30, 2005. This award is not associated with a larger...
This federal contract award, valued at $400,734.35, was made by the Defense Health Agency to Duke University, a private non-profit university, for a new research contract. The award does not have a set-aside designation. The contract is a definitive contract of the cost-no-fee pricing type, with a performance period ending on December 29, 2018. Duke University's Office of Research Administration Division is the prime contractor. The award indicates that Duke University has been awarded...
The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract to Duke University Office of Research Administration Division for the "Evaluating Fitness-for-Use of Electronic Health Records in Clinical Research" project. The contract has a potential value of $1,269,675.26 and a completion date of December 30, 2022. This contract is not set aside. As the prime contractor, Duke University will provide clinical research and...
Duke University is the prime contractor on a $1,609,333 cost-no-fee definitive contract with the Department of Health and Human Services' Food and Drug Administration to perform research titled "Quantifying Patients' Benefit-Risk Tradeoffs Associated with Percutaneous Revascularization Options for Peripheral Arterial Disease: A Collaborative Effort with the Rapid Pathways Patient Science Working Group." There is no set-aside designation. Major subcontractors include the University of...
This is a $537,041.46 firm-fixed-price definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Duke University for research services related to DNA extractions. The contract has an ultimate completion date of September 13, 2017. The contract was awarded on September 14, 2015 and was not set aside for any socioeconomic program. Duke University, through its Office of Research Administration Division, is the prime contractor for this award. The contract aligns with Duke's...
This federal contract award, valued at $454,411.00, was made by the Department of Veterans Affairs (VA) to Duke University's Office of Research Administration Division. The contract is for brain imaging research, with an ultimate completion date of September 30, 2017. The contract type is Definitive Contract with a Firm Fixed Price pricing structure. No set-aside designation was used for this award. Duke University has been awarded numerous federal contracts and grants across various...
Duke University has been awarded a firm fixed price purchase order totaling $22,137 by the Department of Health and Human Services Food and Drug Administration. The contract is for technical expertise in predictive toxicology for drug-induced liver injury to be delivered through April 2025 in Durham, North Carolina. As the prime contractor, Duke University will provide technical expert services through its Office of Research Administration to support the FDA's predictive toxicology programs....